"@ProfMaurer #EAACI2023 on #Lirentelimab, an anti-sialic acid-binding immunoglobulin-like lectin 8 mAb, selectively inhibits mast cells and depletes eosinophils, in inducible urticaria"

lirentelimab (AK002) - Allakos

Jun 10, 2023